Researchers at Stanford Medicine, the University of California San Diego, and Oxford University have pioneered a groundbreaking wearable ultrasound patch designed specifically for continuous fetal monitoring in high-risk pregnancies. Unlike conventional fetal surveillance methods that offer only intermittent snapshots, this novel adhesive device adheres directly to the maternal abdomen, delivering real-time, continuous insight into critical blood flow dynamics within the fetus and umbilical cord. Early trials have demonstrated significant potential for transforming prenatal care strategies, especially for pregnancies complicated by intrauterine growth restriction (IUGR), a significant condition affecting approximately 10% of pregnancies where compromised nutrient and oxygen supply leads to restricted fetal development.
The development and preliminary validation of this ultrasound patch were published in the May 26 issue of Nature Biotechnology, highlighting its innovative design and promising clinical applications. Intrauterine growth restriction poses complex challenges in obstetrics, often compelling physicians to make difficult decisions about the timing of delivery to mitigate risks such as stillbirth without exposing the neonate to the hazards of premature birth. The wearable patch addresses a crucial gap in fetal monitoring by enabling close, continuous tracking of blood flow, an essential parameter in evaluating fetal health in these scenarios.
Traditional fetal monitoring methods primarily rely on intermittent Doppler ultrasound examinations that capture fleeting images of fetal blood flow. These techniques necessitate appointment scheduling and the presence of skilled technicians, making frequent, continuous monitoring impractical. Additionally, cardiotocography, a standard method measuring fetal heart rate and uterine contractions through electronic sensors strapped to the maternal abdomen, often struggles with signal reliability due to fetal movement, limiting its utility for extended observation periods. The stress imposed on both patients and healthcare providers by the labor-intensive nature of current monitoring underscores the urgent need for a more user-friendly and reliable solution.
The ultrasound patch’s technical innovation lies in its flexible, adhesive design coupled with sophisticated imaging algorithms. Measuring approximately the size of a human palm, the patch connects to a computational system via cable, interpreting ultrasound signals into detailed blood flow data. One of the most formidable challenges the researchers overcame was the dynamic nature of the prenatal environment: the fetus frequently moves and changes position, the umbilical cord floats freely in amniotic fluid, and the maternal abdomen itself undergoes regular motion. Conventional ultrasound setups mitigate these variables through manual repositioning of the transducer; however, the wearable patch required an automated tracking solution.
To surmount this, the researchers implemented an advanced image segmentation algorithm that locks onto the placental insertion site of the umbilical cord—a relatively stable anatomical landmark despite overall fetal and maternal movement. This algorithm enables continuous real-time visualization without manual adjustment, ensuring consistent data quality regardless of maternal activity or the fetus’s orientation. Rigorous testing on simulation mannequins preceded clinical validation to confirm that the device adhered to safety standards regulated by the U.S. FDA, the American Institute of Ultrasound in Medicine, and the British Medical Ultrasound Society, particularly concerning acoustic and mechanical energy emissions to ensure fetal safety.
Clinical validation involved a cohort of 62 pregnant individuals, spanning various stages and conditions, in whom the patch’s data were directly compared to those obtained via conventional Doppler ultrasound machines. Statistical analysis revealed equivalence in performance, demonstrating the patch’s capacity to reliably capture blood flow velocity and volume in the two umbilical arteries and the umbilical vein, as well as flow within a major fetal artery. Notably, the patch’s imaging capabilities extend beyond vascular assessment, allowing measurement of critical fetal anatomical parameters such as head circumference, abdominal circumference, and femur length, which are instrumental in estimating fetal weight and diagnosing growth anomalies.
An extraordinary outcome of the clinical trial was the early detection of a severe vascular abnormality in a participant at 28 weeks’ gestation. Initial fetal heart rate assessments appeared normal; however, the ultrasound patch revealed abnormal fluctuations in umbilical cord blood flow. Confirmatory follow-up evaluations verified significant placental dysfunction, prompting intensive monitoring and ultimately enabling timely cesarean delivery. The neonate, though initially requiring intensive care, demonstrated favorable progress, underscoring the patch’s potential lifesaving impact through early risk identification.
Future directions for this technology include the development of a wireless iteration of the patch to facilitate outpatient monitoring, thereby extending its utility beyond the hospital setting. Further research will explore its application across a broader spectrum of pregnancy complications characterized by compromised blood flow, such as congenital heart disease and chronic maternal hypertension. These expansions could revolutionize prenatal care by providing clinicians with a continuous stream of meaningful, actionable data, improving decision-making during critical junctures in complicated pregnancies.
The collaboration between clinical experts, biomedical engineers, and computer scientists has yielded a device that could markedly alleviate the logistical and technical barriers currently impeding optimal fetal monitoring. Dr. Jane Chueh, a high-risk obstetrician collaborating on this project, emphasizes the transformative potential of having immediate, continuous information available without the burden of repeated technician input or complex setups. This level of monitoring granularity not only enhances patient care but may also reduce the anxiety and physical strain for expectant mothers, especially those requiring hospitalization.
Broadly, the wearable ultrasound patch exemplifies how evolutionary advances in wearable technology, artificial intelligence, and medical imaging can converge to address longstanding challenges in prenatal medicine. By targeting the placental insertion of the umbilical cord as a stable anchor point for imaging, the device innovatively tackles the inherent problem of movement artifacts—a significant limitation in traditional ultrasound diagnostics. From a physiological standpoint, persistent monitoring of umbilical and fetal artery flow is invaluable in early detection of fetal distress, potentially preempting adverse outcomes and optimizing delivery timing.
The project’s financial backing from the National Institutes of Health, alongside support from Wellcome Leap and UC San Diego’s Accelerating Innovation to Market program, has been integral to the multidisciplinary effort needed to advance this technology from concept to clinical reality. Continued funding will be essential for larger-scale trials, refinement of wireless capabilities, and integration with existing prenatal monitoring infrastructure.
Ultimately, this ultrasound patch holds the promise not only of redefining fetal monitoring standards in high-risk obstetrics but also of inspiring parallel innovations in remote maternal-fetal health surveillance. Its adoption could usher in a new era where pregnancy care is more personalized, proactive, and accessible, thereby improving outcomes for mothers and their babies worldwide.
Subject of Research: People
Article Title: Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch
News Publication Date: 26-May-2026
Web References: https://www.nature.com/articles/s41587-026-03140-1
References: 10.1038/s41587-026-03140-1
Keywords: Pregnancy, Pregnancy complications, Fetal monitoring, Wearable ultrasound, Intrauterine growth restriction, Fetal blood flow, Obstetrics, High-risk pregnancy, Medical devices, Prenatal care
